GET A SECOND MEDICAL OPINION WITHIN 48 HOURS!
⚡ PSMA THERAPY IN TURKEY (LUTETIUM-177 PSMA THERAPY)
Advanced Targeted Therapy for Prostate Cancer with Lutetium-177
PSMA Therapy (Prostate-Specific Membrane Antigen Therapy) — also known as Lu-177 PSMA Therapy — is one of the most innovative and effective treatments available today for advanced or metastatic prostate cancer.
It offers hope to patients whose cancer no longer responds to hormone therapy or chemotherapy.
At Medicine Park International, we help patients from Romania and around the world access state-of-the-art PSMA therapy centers in Turkey, where world-class nuclear medicine specialists deliver this targeted treatment with precision and care.
💡 What Is PSMA Therapy?
PSMA (Prostate-Specific Membrane Antigen) is a protein found in large quantities on the surface of prostate cancer cells.
In PSMA therapy, a molecule that specifically targets these proteins is combined with a radioactive isotope — most commonly Lutetium-177 (Lu-177).
When injected into the bloodstream, this compound seeks out and attaches to PSMA-positive cancer cells, delivering targeted radiation directly to the tumor, while sparing healthy tissues.
This makes PSMA therapy:
Highly effective, even in advanced or metastatic cancer
Safe, with manageable side effects
Personalized, as it targets cancer cells specifically
⚕️ WHO CAN BENEFIT FROM PSMA THERAPY?
PSMA Therapy is mainly used in patients with:
Metastatic castration-resistant prostate cancer (mCRPC)
Recurrent prostate cancer after surgery or radiotherapy
Bone or lymph node metastases
Limited treatment options after hormone or chemotherapy
Before treatment, a PSMA PET-CT scan is performed to confirm that the tumor cells express PSMA receptors.
🧬 HOW PSMA THERAPY WORKS
Eligibility Assessment
A PSMA PET-CT scan identifies patients who can benefit from therapy.
Blood and kidney function are checked to ensure safety.Administration of Lu-177 PSMA
The radioligand (Lu-177 PSMA-617 or PSMA-I&T) is injected intravenously.
It circulates through the body, binding specifically to prostate cancer cells.Radiation Action
Once attached, the Lu-177 emits beta radiation that destroys tumor cells from within while minimizing damage to nearby healthy tissue.Follow-Up
Imaging and lab tests are performed after each treatment cycle to evaluate progress.
🌍 WHY CHOOSE TURKEY FOR PSMA THERAPY?
Turkey has become a global leader in advanced nuclear medicine therapies, including Lu-177 PSMA treatment, thanks to its combination of technology, expertise, and affordability.
Key advantages:
🧪 Experienced nuclear medicine doctors trained in Europe and the U.S.
🏥 Modern facilities equipped for Lu-177 production and application
🕒 Fast scheduling and short waiting times
💰 Affordable prices compared to Western Europe
🌐 Reports and imaging in English
✈️ Comprehensive medical travel coordination by Medicine Park International
Thousands of patients choose Turkey every year for safe, effective, and well-organized cancer care.
✈️ HOW MEDICINE PARK INTERNATIONAL HELPS YOU
We handle everything — from medical coordination to travel arrangements — for a smooth and stress-free experience.
Free case review: send your medical reports and PSMA PET-CT results.
Eligibility confirmation: partner hospital verifies suitability for Lu-177 therapy.
Personalized treatment plan: transparent costs and timeline for all cycles.
Full travel organization: flights, hotel, transfers, interpreter.
On-site support: our coordinators accompany you during your stay.
Continuous follow-up: we monitor your progress after each session.
Our mission is to make advanced prostate cancer treatment accessible, affordable, and humane.
